Medicare Advantage − the private option that costs taxpayers extra and requires prior approval − is the default for some state agencies and corporations.
Susan Monarez, Trump’s nominee for CDC director, faces an unprecedented and tumultuous era at the agency Health – The Conversation
Trump’s nominee for the top CDC role would join the agency at a time of great turmoil and uncertainty for medical research.
Hormone therapy may cut cardiovascular risk in younger menopausal women Health – The Conversation
A more nuanced understanding of hormone therapy now suggests that its benefits for heart health depend on how soon after menopause onset it is prescribed.
Hard work feels worth it, but only after it’s done – new research on how people value effort Science + Tech – The Conversation
Researchers probed what psychologists call the ‘paradox of effort’ to learn how different people value work they could do in the future or that they’ve already accomplished in the past.
Being alone has its benefits − a psychologist flips the script on the ‘loneliness epidemic’ Health – The Conversation
Americans are spending more of their time alone. Contrary to national fears of a loneliness crisis, many of them find solitude essential for their well-being.
Molecular Hydrogen Therapy: Do Dogs With Lung Cancer Have Hope After All?
Hydrogen inhalation therapy for canine dog cancer…it’s safe and effective.
Editors’ Picks, March 2025: Cancer Cell Senescence, Ultraviolet Protection, and More American Association for Cancer Research (AACR)
This month, the editors of AACR’s journals tout studies showcasing the immunostimulatory impact of senescent cancer cells, a novel bispecific immunotherapy, and more.
The post Editors’ Picks, March 2025: Cancer Cell Senescence, Ultraviolet Protection, and More appeared first on American Association for Cancer Research (AACR).
Personalized Vaccines and Beyond: Confronting the Complex Biology of Kidney Cancer American Association for Cancer Research (AACR)
A promising new personalized vaccine headlines several recent breakthroughs that highlight progress in kidney cancer research.
The post Personalized Vaccines and Beyond: Confronting the Complex Biology of Kidney Cancer appeared first on American Association for Cancer Research (AACR).
Cancer Today’s Spring 2025 Issue: How Liquid Biopsies Can Guide Treatment Decisions, Extending Survival in Treatment-resistant Breast Cancer, and More American Association for Cancer Research (AACR)
After Craig Schumpert learned he had lung cancer that had spread to his brain, bones, and lymph nodes, he started radiation therapy. His oncologist told him he might be eligible for targeted therapy, but he would have to wait four to six weeks for results from tumor tissue testing. The possibility of targeted therapy sounded
The post Cancer Today’s Spring 2025 Issue: How Liquid Biopsies Can Guide Treatment Decisions, Extending Survival in Treatment-resistant Breast Cancer, and More appeared first on American Association for Cancer Research (AACR).
Meet The CheckPoints: A Band of Researchers and Oncologists Giving Cancer Treble American Association for Cancer Research (AACR)
The CheckPoints is a band comprised of cancer researchers, medical oncologists, and other professionals in the field of immuno-oncology.
The post Meet The CheckPoints: A Band of Researchers and Oncologists Giving Cancer Treble appeared first on American Association for Cancer Research (AACR).